Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: DM 475207-59-1
Purity: 99%
Appearence: White Powder
Packaging: As required
Transportation: Ocean,Air
Place of Origin: Stock available
Certificate: ISO9001
Port: Shanghai,Shenzhen,Qingdao
Payment Type: L/C,T/T,D/P,Paypal,Others
Incoterm: FOB,CIF
Pharmaceutical Grade Sorafenib tosylate CAS:475207-59-1
Name: 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate
CAS No.:475207-59-1
Other Names:SORAFENIB-D3
MF:C21H16ClF3N4O3 C7H8SO
Place of Origin: China
Purity:≥99%
Molecular Weight:637.03
Appearance: White Powder
Sorafenib tosylate is a new multi-targeted anti-tumor drug developed by Bayer AG in Germany that can act on both tumor cells and tumor blood vessels. It has a dual antitumor effect: it can directly inhibit the proliferation of tumor cells by blocking the cell signaling pathway mediated by RAF / MEK / ERK, and can also inhibit the growth of tumor cells by inhibiting VEGF and platelet-derived growth factor (PDGF) receptors Blocking the formation of neovascularization, indirectly inhibiting the growth of tumor cells.
Our productions of Sorafenib Intermediates:
Product Categories : APIs And Intermediates > Sorafenib Intermediates
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.